Anthera Pharmaceuticals Inc 4
4 · Anthera Pharmaceuticals Inc · Filed Jan 2, 2015
Insider Transaction Report
Form 4
LIU MAY
Chief Accounting Officer
Transactions
- Award
Stock option (right to buy)
2014-12-30+120,000→ 120,000 totalExercise: $1.61Exp: 2024-12-30→ Common Stock (120,000 underlying)
Holdings
- 19,802
Common Stock
Footnotes (2)
- [F1]Includes 12,500 acquired under the Issuer's 2010 Employee Stock Ownership Plan on December 31, 2014 and 187 shares of stock acquired through the vesting of restricted stock units, which represent the portion of the Reporting Person's 2010 performance share award.
- [F2]This stock option vests monthly over four years beginning December 30, 2014 (the Vesting Start Date). The Stock Option is completely vested on the fourth anniversary of the vesting start and will expire on December 30, 2024.